• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP

LTR PHARMA LIMITED - Charts / Financials

3.80% ! 41.0¢
Market Cap $71.80M  !
Healthcare Biotechnology
Add to My Watchlist

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.More

refresh Created with Sketch. REFRESH
Last update - 16.10pm 21/04/2026 (20 minute delay) ?
Day
Open 40.0¢   Day High 41.5¢   Day Low 40.0¢
Daily Volume 105459
Bids   Sellers
Number Price Volume   Number Price Volume
0 40.5¢ 2463   0 41.5¢ 672

Directors & Senior Management

Dr. Amy Pearlman Member of the Scientific Advisory Board
Dr. Andrew Y. Sun Member of Scientific Advisory Board
Mr. Danny Zanardo Chief Commercial Officer
Prof. Darren Katz Member of the Scientific Advisory Board
Ms. Elizabeth Spooner Joint Company Secretary
Associate Prof. Eric Chung Member of the Scientific Advisory Board
Mr. Euh Hwang Joint Company Secretary
Prof. Geoffrey A. Strange Chief Medical Officer
Mr. Jacques Schipper Chief Financial Officer
Jay Rodne Director of LTR Inc.
Dr. Julian John Chick Independent Non-Executive Director
Mr. Lee Rodne Executive Chairman
Ms. Maja Aleksandra McGuire Independent Non-Executive Director
Ms. Melissa Hadley Barrett Member of the Scientific Advisory Board
Mr. Peter McLennan Chief Operating Officer

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
41.0¢ 		Change
0.015(3.80%) 		Mkt cap ! $71.80M
Open High Low Volume
40.0¢ 41.5¢ 40.0¢ 105.4K

Buyers (Bids)

Vol. Price($)
2463 40.5¢
 

Sellers (Offers)

Price($) Vol.
41.5¢ 672
Last trade - 16.10pm 21/04/2026 (20 minute delay) ?

Top Stories

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre. In this segment, we wrap up the stocks and company announcements you were watching this week on Australia’s #1 finance website. Let’s get straight into it, star...
Introducing Diablo Resources: A US critical minerals story entering its next exploration phase The latest HotCopper Capital Compass, where we’ve spoken to Diablo Resources CEO Lyle Thorne about the explorer's maiden drilling in Utah.
Australia metals exploration spend tipped to bounce back this year According to a new report, global exploration budgets declined for the third consecutive year, although Australia is a bright spot.
Prairie's reality: Execution has become new alpha in North American lithium race As any good HotCopper reader worth their salt knows ⁠@ and I know you’re one of them, dear reader ⁠@ the lithium narrative has long hinged on two variables: Resource size and grade. Our HotCopper forums are filled with investors scouring feasibility studies for the...
Ore Resources reports early Phase 4 drilling results pointing to expanding gold system at Forrest prospect Ore Resources (ASX:OR3) is continuing to build momentum at its Coolgardie project in Western Australia, where it’s been rolling out a large-scale Phase 4 drilling program. The company has just released its drilling results from its latest program, and it’s all look...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.